NCT00411567View on ClinicalTrials.gov

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2006

Conditions
Bronchial Asthma
Interventions
DRUG

inhaled corticosteroid therapy

Trial Locations (1)

Unknown

Novartis Investigative Site, Nuremberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00411567 - A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma | Biotech Hunter | Biotech Hunter